{"version":"1.0","type":"card","id":"cdde6ea5-96c7-4265-9703-a294182cc971","url":"https://stacklist.com/card/cdde6ea5-96c7-4265-9703-a294182cc971","title":"Daubert Standard | Wex | US Law | LII","source_url":"https://www.law.cornell.edu/wex/daubert_standard","note":"The Daubert Standard is a legal standard used to determine the admissibility of expert witnesses' testimony in court. It emphasizes the importance of scientific validity and reliability in expert evidence, guiding judges in their gatekeeping role.","image":{"url":"https://ucarecdn.com/c0f3e131-23a3-411e-9abe-e4c3917fd474/","alt":"Daubert Standard | Wex | US Law | LII","width":1280,"height":800},"stack":{"id":"f0068953-0385-4b3b-8cf4-66d421eeff25","title":"Visualize Your Evidence","url":"https://stacklist.com/c/education/stack/f0068953-0385-4b3b-8cf4-66d421eeff25"},"created_at":"2026-08-17T20:22:45.796Z","updated_at":null,"aco":{"summary":"The Daubert Standard is a legal framework established by the 1993 U.S. Supreme Court case Daubert v. Merrell Dow Pharmaceuticals, requiring trial judges to act as gatekeepers by evaluating the reliability and relevance of expert witness testimony before it reaches a jury. It supplanted the older Frye Standard and was further clarified by the Joiner and Kumho Tire decisions, collectively known as the Daubert Trilogy, which also shaped Federal Rule of Evidence 702.","tags":["daubert-standard","expert-testimony","evidence-law","federal-courts","scientific-evidence","trial-procedure","gatekeeping"],"key_entities":[{"name":"Daubert Standard","type":"concept","confidence":1},{"name":"Daubert v. Merrell Dow Pharmaceuticals Inc.","type":"event","confidence":1},{"name":"U.S. Supreme Court","type":"organization","confidence":1},{"name":"Frye Standard","type":"concept","confidence":0.95},{"name":"General Electric Co. v. Joiner","type":"event","confidence":0.9},{"name":"Kumho Tire Co. v. Carmichael","type":"event","confidence":0.9},{"name":"Federal Rule of Evidence 702","type":"concept","confidence":0.9},{"name":"Daubert Trilogy","type":"concept","confidence":0.85},{"name":"expert witness testimony","type":"concept","confidence":0.95},{"name":"Jim Robinson","type":"person","confidence":0.7},{"name":"Merrell Dow Pharmaceuticals","type":"organization","confidence":0.85},{"name":"Frye v. United States","type":"event","confidence":0.9}],"classification":"reference","language":"en","confidence":0.85,"provenance":{"model":"claude-opus-4-6","tool":"@stacklist/mcp-server@2.0.0","confidence":0.85,"timestamp":"2026-08-17T20:22:56.060Z"},"token_counts":{"approximate":772,"cl100k":617},"content_hash":"sha256:31ad570a93396dca4be4904c69e26ee3a98f52344bfe8449c7fe272625088a80","acp_version":"0.2","body_available":true,"body_tokens":772,"visibility":"public","agent_accessible":true,"status":"final"},"_links":{"self":"/api/public/card/cdde6ea5-96c7-4265-9703-a294182cc971.json","html":"https://stacklist.com/card/cdde6ea5-96c7-4265-9703-a294182cc971","md":"/api/public/card/cdde6ea5-96c7-4265-9703-a294182cc971.md","stack_json":"/api/public/stack/f0068953-0385-4b3b-8cf4-66d421eeff25.json"}}